Twist Bioscience (TWST) is scheduled to report earnings on January 31, 2025. The last reported earnings were for reported on November 18, 2024 for Q4.

Robert Gordon Joseph does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations ...

Twist Bioscience Corporation (NASDAQ:TWST) Q4 2024 Earnings Call Transcript November 18, 2024 Operator: Welcome to Twist Bioscience's 2024 Fourth Quarter Financial Results Conference Call.

In this article, we are going to take a look at where Twist Bioscience Corporation (NASDAQ:TWST) stands against the other genomics stocks. Genomics is the study of genes and how they function.

Twist Biosciences is headquartered in South San Francisco, CA. The company provides synthetic genes and gene fragments that are used in product development for therapeutics across myriad ...

Adjusted EBITDA of approximately $(20) million with sequential improvements throughout 2025. Price Action: TWST stock is up 12.7% at $41.59 at last check Monday.

Twist Bioscience (TWST) came out with a quarterly loss of $0.59 per share versus the Zacks Consensus Estimate of a loss of $0.73. This compares to loss of $0.81 per share a year ago. These figures ...